No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.

MLA

Dyment, D. A., et al. “No Evidence to Support CTLA-4 as a Susceptibility Gene in MS Families: The Canadian Collaborative Study.” Journal of Neuroimmunology, vol. 123, no. 1–2, Feb. 2002, pp. 193–98. EBSCOhost, https://doi.org/10.1016/s0165-5728(01)00493-3.

APA

Dyment, D. A., Steckley, J. L., Willer, C. J., Armstrong, H., Sadovnick, A. D., Risch, N., & Ebers, G. C. (2002). No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. Journal of Neuroimmunology, 123(1–2), 193–198. https://doi.org/10.1016/s0165-5728(01)00493-3

Chicago

Dyment, D A, J L Steckley, C J Willer, H Armstrong, A D Sadovnick, N Risch, and G C Ebers. 2002. “No Evidence to Support CTLA-4 as a Susceptibility Gene in MS Families: The Canadian Collaborative Study.” Journal of Neuroimmunology 123 (1–2): 193–98. doi:10.1016/s0165-5728(01)00493-3.